Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
SGLT2s
Pharma
Bayer's Kerendia scores kidney and heart disease FDA nod
Bayer's Kerendia grabbed a long-awaited diabetic kidney and heart disease FDA OK, setting up a showdown with AZ's Farxiga and J&J's Invokana.
Noah Higgins-Dunn
Jul 9, 2021 3:30pm
J&J backs new Invokana CV nod with series of awareness tweets
Nov 14, 2018 9:30am
FDA slaps gangrene warning on SGLT2 diabetes drugs
Aug 30, 2018 11:26am
#ACC17 skinny: Yes, PCSK9s, but Xarelto and Entresto, too
Mar 20, 2017 9:06am
